Table 4 Odds ratios of bladder cancer patients for the NAT2 genotype combined with the CYP1A2, SULT1A1, and UGT2B7 genotypes

CYP1A2*1 C/*1A or *1A/*1A

1^b

230/234

2.82 (1.42–5.60)

33/12

<0.01

CYP1A2 *1C/*1C

1.42 (0.65–3.15)

16/11

NC

3/0

NC

SULT1A1*1/*1

1^b

190/192

3.18 (1.46–6.93)

28/9

<0.05

SULT1A1*2/*2 or *1/*2

1.06 (0.69–1.63)

56/53

2.72 (0.71–10.44)

8/3

0.145

UGT2B7 *1/*1

1^b

120/129

2.85 (1.21–6.71)

21/8

<0.05

UGT2B7 *2/*2 or *1/*2

1.16 (0.82–1.66)

126/116

4.20 (1.34–13.14)

15/4

<0.05